Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
NOCD Announces Noto As New Parent Brand, Acquires Rebound Health for PTSD
World’s Largest Virtual Specialty Therapy Company Announces its AI-Enabled Platform, Noto, as its New Parent Brand, Positioned to Power and Transform the Future of Specialty Therapy for Complex Psychiatric and Behavioral Conditions (CPBCs)
This week NOCD, the world’s largest specialty behavioral health treatment company and leader in serving OCD and Related Disorders, announced that Noto, the AI-enabled platform built from scaling NOCD over the past decade, will serve as its new parent brand. In Latin, Noto means “to be known.” Virtual specialties powered by Noto will help people with complex psychiatric and behavioral conditions know what they’re experiencing, access evidence-based treatment, and get better.
The Noto platform has enabled NOCD to deliver over 1 million evidence-based OCD therapy sessions per year, with industry-leading clinical outcomes. Now, Noto is poised to power the next generation of virtual specialties for other complex psychiatric and behavioral conditions, starting with the acquisition of Rebound Health for Trauma Disorders. Noto will serve as the parent brand for both NOCD and Rebound, enabling both to continue scaling nationwide.
Stephen Smith, Co-Founder and CEO at Noto and NOCD, shares the origins of the Noto platform, “We set out to develop a better treatment system that identifies hard-to-reach people with OCD, builds trust with them, and offers them effective, affordable, and convenient care for the root of their suffering, rather than surface-level symptoms. This led to world-class clinical outcomes for our therapy members and substantial savings for our payer partners, allowing us to re-invest in serving more people in need of care. Today, we’ve engaged millions in our online community and enrolled hundreds of thousands in specialized therapy. We couldn’t have scaled to this point if we hadn’t created Noto: the natively-built technology that enables our operations teams to work with payers, enroll hard-to-engage members, and manage treatment operations for our network of full-time, specialty-trained therapists. Now, we feel the responsibility to leverage our Noto platform to scale other virtual specialties for severe, overlooked, but treatable conditions—starting with Rebound for PTSD.”
The Noto platform powers payer administrative functions, member identification & enrollment operations, and clinical training & management—often the biggest and most costly challenges faced by virtual specialty therapy services that focus on complex psychiatric and behavioral conditions. For example, partnerships with health plans nationwide are streamlined with AI-enabled revenue cycle management and purpose-built processes for credentialing and enrolling new therapists. To identify and engage Members of the OCD community, Noto powers awareness campaigns, personalized community feeds, self-help tools, and live events led by experts. And for NOCD’s 1000+ primarily full-time therapists, Noto houses AI-enabled clinical interviewing, a specialized training experience, continuous support and oversight, AI-assisted note-taking, Member communications, outcomes tracking, AI practice sessions, and more.
“As we worked to give our members a personalized, VIP treatment experience, we were limited by the off-the-shelf technology solutions that existed, so we set out to build the technological infrastructure we needed ourselves. After a decade of work, I can confidently say that Noto allows us to deliver a VIP treatment experience and more,” says Anil Vaitla, Co-Founder and CTO at Noto and NOCD.
New specialties launched on Noto will be able to leverage support in these areas more quickly and easily. This is why NOCD’s acquisition of Rebound Health is a significant milestone. “Noto allows my cofounder, Dr. Erin Berenz, PhD, and me to scale a leading specialty therapy service for trauma survivors across the entire country,” says Raeva Kumar, Co-Founder and CEO at Rebound Health…
Full release here, originally announced January 27th, 2026.
Wisp Acquires TBD Health, Launching Enterprise and Hybrid Care Offerings
Acquisition Adds National Care Infrastructure, Diagnostics, and Hospital Partnerships to Wisp’s Women’s Health Platform
Wisp, the largest women’s telehealth company in the U.S., today announced the acquisition of TBD Health, a national sexual health platform and one of the nation’s most scaled TelePrEP infrastructures with deep partnerships with hospital systems, enterprises, and public health organizations. This marks Wisp’s first acquisition and milestone expansion beyond direct-to-consumer care, into enterprise and hybrid care models.
Care is delivered outside of traditional clinical settings now more than ever, through hybrid models that combine consumer-first digital care with hospital systems, enterprises, and public health programs. However, gaps in access remain, particularly in sexual health and preventive care. Despite the availability of preventative treatment, U.S. PrEP adoption is lagging. Of the 2.4 million people eligible for treatment, only ~25% are currently enrolled, signaling a major public health shortfall. Further, while accounting for 19 percent of new HIV diagnoses, women remain significantly underserved by existing prevention models, largely because most solutions have historically been designed and marketed for men.
“This acquisition reflects where healthcare is going and where women have been left behind,” said Monica Cepak, CEO at Wisp. “TBD Health brings the infrastructure and partnerships that allow us to move into hybrid and enterprise care quickly, while staying true to Wisp’s patient-first approach. Together, we are making preventative care more accessible, especially to women, and integrating them into proven care models.”
TBD Health operates a nationally scaled sexual health and diagnostics platform across all 50 states, combining routine STI and HIV testing, virtual clinical support, and strategic partnerships that help remove cost barriers for patients. By bringing together Wisp’s trusted women’s health platform with TBD Health’s national care infrastructure and established health system relationships — including Mount Sinai Health System, San Francisco AIDS Foundation, and Planned Parenthood Direct — the companies aim to expand access to sexual health, diagnostics, and hybrid care models that better reflect how and where patients seek care.
“By joining forces with Wisp, we can provide partners with a turnkey solution for PrEP along with sexual health diagnostics and care that integrates seamlessly into their existing workflows…
Full release here, originally announced January 27th, 2026.
No comments:
Post a Comment